Compare SCYX & AUST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SCYX | AUST |
|---|---|---|
| Founded | 1999 | 2020 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.6M | 22.2M |
| IPO Year | 2014 | 2022 |
| Metric | SCYX | AUST |
|---|---|---|
| Price | $0.66 | $1.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 563.4K | 86.5K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,932,000.00 | N/A |
| Revenue This Year | $167.73 | N/A |
| Revenue Next Year | $290.78 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.57 | $1.05 |
| 52 Week High | $1.49 | $2.94 |
| Indicator | SCYX | AUST |
|---|---|---|
| Relative Strength Index (RSI) | 45.86 | 57.35 |
| Support Level | $0.65 | $1.61 |
| Resistance Level | $0.72 | $1.85 |
| Average True Range (ATR) | 0.05 | 0.16 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 54.91 | 73.77 |
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
Austin Gold Corp is focused on the acquisition, exploration and evaluation of mineral resource properties in the western United States of America (USA). Exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek in Humboldt County, Lone Mountain and Miller in Elko County, and Stockade Mountain (Oregon).